![Roy Herbst shared the updated results from the COAST clinical trial – Yale Cancer Center](https://oncodaily.com/pub/uploads/2024/06/Roy-Herbst-e1717531507594-1280x721.jpg)
Photo taken from Yale Cancer Center/X
Jun 6, 2024, 04:19
Roy Herbst shared the updated results from the COAST clinical trial – Yale Cancer Center
Yale Cancer Center shared a post on X:
“Roy Herbst shared the updated results from the COAST clinical trial, a phase 2 study of durvalumab with/without oleclumab or monalizumab in patients with stage 3 unresectable NSCLC.”
Source: Yale Cancer Center/X